ACRS earnings
Aclaris Therapeutics (ACRS) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
ACRS earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | -0.15 | -0.16 | 6.25% | $1.63M |
| Q1 2026 | May 7, 2026 | -0.15 | -0.16 | 6.25% | $2.00M |
| Q4 2025 | Feb 26, 2026 | -0.16 | -0.15 | -6.67% | $1.29M |
| Q3 2025 | Nov 6, 2025 | -0.12 | -0.13 | 7.69% | $3.30M |
| Q2 2025 | Aug 7, 2025 | -0.13 | -0.13 | 0.00% | $1.78M |
| Q1 2025 | May 8, 2025 | -0.12 | -0.17 | 29.41% | $1.46M |
| Q4 2024 | Feb 27, 2025 | -1.01 | -0.32 | -215.62% | $9.21M |
| Q3 2024 | Nov 6, 2024 | -0.11 | -0.08 | -37.50% | $4.35M |
| Q2 2024 | Aug 7, 2024 | -0.15 | -0.19 | 21.05% | $2.77M |
| Q1 2024 | May 7, 2024 | -0.24 | -0.28 | 14.29% | $2.40M |
| Q4 2023 | Feb 26, 2024 | -0.02 | -0.37 | 94.59% | $17.57M |
| Nov 6, 2023 | -0.41 | -0.48 | 14.58% | – | |
| Aug 7, 2023 | -0.42 | -0.45 | 6.67% | – | |
| May 8, 2023 | -0.42 | -0.44 | 4.55% | – | |
| Feb 23, 2023 | -0.41 | -0.46 | 10.87% | – | |
| Nov 8, 2022 | -0.30 | -0.39 | 23.08% | – | |
| Aug 3, 2022 | -0.31 | -0.36 | 13.89% | – | |
| May 10, 2022 | -0.31 | -0.39 | 20.51% | – | |
| Feb 24, 2022 | -0.37 | -0.36 | -2.78% | – | |
| Nov 2, 2021 | -0.35 | -0.27 | -29.63% | – |
- ACRS beat EPS estimates in 27 of its last 44 reports.
Updated 2026-11-07 11:55 UTC